{"id":62411,"date":"2025-12-26T19:05:51","date_gmt":"2025-12-26T18:05:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/"},"modified":"2025-12-26T19:05:51","modified_gmt":"2025-12-26T18:05:51","slug":"1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/","title":{"rendered":"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/6182146\/clinical-trial-agreements-key-legal-regulatory?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=t74hc4&amp;utm_campaign=2124177+-+1+Day+Clinical+Trial+Agreements+Training+Course%3A+Key+Legal%2C+Regulatory+and+IP+(Intellectual+Property)+Considerations+for+the+EU+(European+Union)+and+UK+Markets++(Mar+18%2C+2026)&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">&#8220;Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)&#8221;<\/a> training has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/22\/logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/21\/logo.jpg\"><\/a><\/p>\n<p>\n<strong>The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector.<\/strong> Having appropriate CTAs in place is therefore essential for managing relationships between the different stakeholders, and apportioning risk and responsibilities between them. If appropriate contractual arrangements are not in place, a clinical trial may not receive approval or issues may arise with the integrity or validity of the data collected. Further, disputes between the parties can arise if responsibilities are not clearly defined in the agreement.<\/p>\n<p>\nThis intensive short course provides essential insights into the legal framework governing clinical trials in the EU and UK, ensuring compliance, protecting intellectual property and managing liability risks.<\/p>\n<p>\nThe expert speakers will explain the dynamic and increasingly demanding regulatory and data protection landscape to better inform those negotiations and drafting these agreements.<\/p>\n<p>\n<strong>Benefits of attending<\/strong><\/p>\n<p>\nBy attending this seminar you will:<\/p>\n<ul>\n<li>\n<strong>Learn<\/strong> about the regulatory framework concerning clinical trials in the EU and the UK<\/li>\n<li>\n<strong>Understand<\/strong> the EU Clinical Trial Regulation and UK Human Use (Clinical Trials) (Amendment) Regulations 2024<\/li>\n<li>\n<strong>Examine<\/strong> the roles and obligations of stakeholders including sponsors, CROs, investigators, and ethics committees<\/li>\n<li>\n<strong>Navigate<\/strong> clinical trials approval, ethical approvals, policy issues, and the legal risks of non-compliance<\/li>\n<li>\n<strong>Master<\/strong> informed consent, clinical trial transparency, and compensation models to mitigate legal exposure<\/li>\n<li>\n<strong>Learn<\/strong> how to protect IP rights in clinical trials, draft strong confidentiality agreements, and manage publication clauses.<\/li>\n<\/ul>\n<p>\n<strong>Who Should Attend:<\/strong><\/p>\n<p>\n<strong>This course has been specially designed for:<\/strong><\/p>\n<ul>\n<li>\nLawyers and in-house legal teams<\/li>\n<li>\nContract managers<\/li>\n<li>\nClinical contract specialists<\/li>\n<li>\nClinical trial managers and professionals<\/li>\n<li>\nR&amp;D staff<\/li>\n<li>\nRegulatory specialists<\/li>\n<li>\nAnd CROs, sponsors and healthcare organisations looking to stay ahead in an evolving legal landscape.<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<p>\n<strong>Overview of the regulation of clinical trials &#8211; the legal framework governing clinical trials in the EU and the UK<\/strong><\/p>\n<ul>\n<li>\nWhat a clinical trial is and the types of clinical trials<\/li>\n<li>\nWho the stakeholders are and their roles and obligations<\/li>\n<li>\nEU regulatory framework under the Clinical Trial Regulation 536\/2014\/EU and the Clinical Trials Information System (CTIS)<\/li>\n<li>\nUK framework post Brexit under the Human Use (Clinical Trials) (Amendment) Regulations 2024<\/li>\n<li>\nClinical trial approval, ethics approval and policy issues (eg Health Research Authority approval)<\/li>\n<li>\nWhat could happen if a clinical trial is not conducted in accordance with the law<\/li>\n<\/ul>\n<p>\n<strong>Consent, data and IP rights<\/strong><\/p>\n<p>\nSponsors and CROs must meet obligations relating to transparency, participant consent and data protection in clinical trials. In turn, those obligations have an impact on parties&#8217; liability risks and IP rights. This session will examine:<\/p>\n<ul>\n<li>\nParticipant consent and liability risks:<\/p>\n<ul>\n<li>\nTransparency obligations and the publication of clinical trials outcomes<\/li>\n<li>\nHow transparency and consent interact with liability risks, including:<\/p>\n<ul>\n<li>\nCompensation models<\/li>\n<li>\nClinical trials insurance<\/li>\n<li>\nProduct liability risks for licensed products<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li>\nData protection:<\/p>\n<ul>\n<li>\nOverview of the requirements<\/li>\n<li>\nUse of patient data during and after a clinical trial (particularly in light of the 3\/2019 guidance from the European Data Protection Board)<\/li>\n<\/ul>\n<\/li>\n<li>\nIntellectual property rights:<\/p>\n<ul>\n<li>\nRelevant IP rights associated with clinical trials<\/li>\n<li>\nHow to best protect any accruing IP rights<\/li>\n<li>\nDrafting and negotiating of IP rights, confidentiality and publication clauses<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\n<strong>Final questions<\/strong><\/p>\n<p>\nFor more information about this training visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/6182146\/clinical-trial-agreements-key-legal-regulatory?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=t74hc4&amp;utm_campaign=2124177+-+1+Day+Clinical+Trial+Agreements+Training+Course%3A+Key+Legal%2C+Regulatory+and+IP+(Intellectual+Property)+Considerations+for+the+EU+(European+Union)+and+UK+Markets++(Mar+18%2C+2026)&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/6n17d8<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;o:&#x70;&#x72;&#x65;&#115;&#115;&#64;r&#x65;&#x73;&#x65;&#97;&#114;ch&#x61;&#x6e;&#x64;&#109;&#97;rk&#x65;&#x74;&#x73;&#46;&#99;om\" rel=\"nofollow\" shape=\"rect\">pr&#101;&#115;&#x73;&#x40;&#x72;&#x65;se&#97;&#114;&#x63;&#x68;&#x61;&#x6e;dm&#97;&#114;&#107;&#x65;&#x74;&#x73;&#x2e;co&#109;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)&#8221; training has been added to ResearchAndMarkets.com&#8217;s offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62411","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)&#8221; training has been added to ResearchAndMarkets.com&#8217;s offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-26T18:05:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2025-12-26T18:05:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/\"},\"wordCount\":668,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251226139824\\\/en\\\/2678432\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/\",\"name\":\"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251226139824\\\/en\\\/2678432\\\/22\\\/logo.jpg\",\"datePublished\":\"2025-12-26T18:05:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251226139824\\\/en\\\/2678432\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251226139824\\\/en\\\/2678432\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)&#8221; training has been added to ResearchAndMarkets.com&#8217;s offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-26T18:05:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) &#8211; ResearchAndMarkets.com","datePublished":"2025-12-26T18:05:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/"},"wordCount":668,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/","name":"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/22\/logo.jpg","datePublished":"2025-12-26T18:05:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251226139824\/en\/2678432\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/1-day-clinical-trial-agreements-training-course-key-legal-regulatory-and-ip-intellectual-property-considerations-for-the-eu-european-union-and-uk-markets-mar-18-2026-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62411"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62411\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}